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Abstract
Background: Detecting candidate B-cell epitopes in a protein is a basic and fundamental step in
many immunological applications. Due to the impracticality of experimental approaches to
systematically scan the entire protein, a computational tool that predicts the most probable epitope
regions is desirable.
Results: The Epitopia server is a web-based tool that aims to predict immunogenic regions in
either a protein three-dimensional structure or a linear sequence. Epitopia implements a machine-
learning algorithm that was trained to discern antigenic features within a given protein. The Epitopia
algorithm has been compared to other available epitope prediction tools and was found to have
higher predictive power. A special emphasis was put on the development of a user-friendly
graphical interface for displaying the results.
Conclusion: Epitopia is a user-friendly web-server that predicts immunogenic regions for both a
protein structure and a protein sequence. Its accuracy and functionality make it a highly useful tool.
Epitopia is available at http://epitopia.tau.ac.il and includes extensive explanations and example
predictions.
Background
The detection of highly immunogenic regions within a
given protein, specifically those that elicit a humoral
immune response i.e., B-cell epitopes, is central to many
immunodetection and immunotherapeutic applications
[1,2]. An unguided experimental search for such regions is
clearly laborious and resource-intensive. Thus, computa-
tional approaches that are able to perform this task are
desired.
Extensive studies regarding the physico-chemical and
structural aspects of antibody-antigen molecular recogni-
tion have provided several important characteristics of a
typical epitope [3-6]. With this rich information at hand
and the availability of state-of-the-art pattern recognition
and classification algorithms, a computational tool that
predicts the most antigenic regions in a protein, which can
thus be approximated as immunogenic, is called for.
Indeed, several such tools have been developed over the
years. Some only rely on properties that can be extracted
from the linear sequence of the antigen (ABCpred [7] and
COBEpro [8]), while others rely on an available three-
dimensional (3D) structure (CEP [9] and DiscoTope
[10]). Other structure-based tools can be applied to linear
sequences if a structural homolog can be found (ElliPro
[11]). Yet, to date, no tool has been reported to perform
its predictions either on the structure or directly on the
sequence, if a structure is unavailable.
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Here we present the Epitopia server, which implements a
machine-learning based algorithm to predict immuno-
genic regions as candidate B-cell epitopes using either the
3D structure or the sequence of a given protein. We com-
pare the performance of Epitopia to several other tools
that either predict B-cell epitopes given a protein 3D struc-
ture or sequence alone and show that it has greater predic-
tive power.
The Epitopia algorithm infers the immunogenic potential
at the single amino-acid site resolution. Epitopia com-
putes an immunogenicity score for each solvent accessible
residue if a 3D structure was provided as input or a score
for every amino-acid if a sequence input was provided. In
addition, Epitopia combines a powerful visualization tool
that color-codes the immunogenicity scores on either the
protein sequence or the 3D structure to provide the users
with a perceptible image of the immunogenic nature of
their studied protein.
Herein we provide a short description of the Epitopia
methodology. More detailed descriptions are available
under the 'OVERVIEW', 'GALLERY', and 'QUICK HELP'
web sections. We exemplify the use of Epitopia by predict-
ing immunogenic regions for both a 3D structure and a
sequence input. Finally, we report its performance on a
benchmark dataset and compare it to other available
tools.
Implementation
The Epitopia algorithm [12] uses a Naïve Bayes classifier
to predict the immunogenic potential of protein regions.
The classifier was trained to recognize immunogenic
properties using a benchmark dataset of 66 non-redun-
dant validated epitopes derived from antibody-antigen
co-crystal structures (an updated dataset compared to
[11]), and 194 non-redundant validated epitopes derived
from antigen sequences (for further reading about the
data and immunogenic properties please refer to [13] and
the 'OVERVIEW' web section, respectively).
A given antigen input is divided to overlapping surface
patches (or stretches in the case of a linear sequence
input), with the size of a typical epitope. Epitopia then
computes for each patch (or stretch) the probability that
it was drawn from the population of epitopes on which
the classifier has been trained, with respect to each one of
its physico-chemical and structural-geometrical proper-
ties. The immunogenicity score is thus the sum of logs of
these probabilities and is assigned to the central residue of
the patch (or to the middle residue in the linear stretch)
[12].
The immunogenicity score reflects the immunogenic
potential of a certain residue relative to all residues in the
antigen. In order to have a more intuitive measure of
immunogenic potential, we also provide a probabilistic
score. To this end, we first divided all site-specific immu-
nogenicity scores in the training data to quantiles (octiles
for the structure data and noniles for the sequence data).
For each quantile, we computed the fraction of validated
epitope residues out of the total number of residues in the
quantile. This number approximates the probability that
a residue with a given immunogenicity score that falls in
this quantile is an epitope residue.
We note that in structure-based predictions our method
refers only to solvent exposed residues since, similar to
other types of protein-protein interfaces, buried residues
are not actively participating in the interaction. In cases
where a studied protein may undergo cleavage which
results with peptides that may become B-cell epitopes
themselves [14], the 3D structure may not be relevant for
the prediction and the sequence-based prediction should
thus be used.
Epitopia input
For a protein 3D structure input, Epitopia requires a pro-
tein data bank (PDB [15]) file (or its identifier), which can
either be an X-ray crystal model or a representative NMR
model of the protein of interest. In addition, the user
should specify the relevant chains to which Epitopia
should relate in one of the following options: (1) if all of
the chains in the model should be related to, either all
chain identifiers or the term "all" should be specified; (2)
if only a subset of chains in the model should be related
to, the corresponding chain identifiers should be speci-
fied. All non-selected chains will thus be removed from
the model file in the preprocess stage; (3) the non-selected
chains can be kept by marking the relevant checkbox. In
this case, the structural-geometrical considerations for
computing the immunogenicity scores will be affected by
all the chains in the model, but immunogenicity scores
will only be computed for the residues of the selected
chains.
For a protein sequence input, the amino-acid sequence
may either be pasted or a local sequence file can be
uploaded. In either case, the sequence should be in Fasta
format and should contain only standard amino acids.
The input is then preprocessed and several stand-alone
executables are used to extract some of the physico-chem-
ical and structural-geometrical properties required for
Epitopia. Further details regarding the preprocess stage are
available under the 'OVERVIEW' web section.
Epitopia output
The immunogenicity and corresponding probability
scores are computed by Epitopia for each surface residue
for a 3D structure input or for every amino-acid for a
sequence input. In either case, these scores are given as aBMC Bioinformatics 2009, 10:287 http://www.biomedcentral.com/1471-2105/10/287
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text file link. In addition, the immunogenicity scores are
color-coded and projected onto the protein. The visualiza-
tion tool that is used for the 3D structure case is the First-
Glance in Jmol interface [16], which enables a wide range
of display options. Along with that, Epitopia also provides
a RasMol command script for viewing the results locally
with the RasMol program [17].
For the sequence output case, an automatic search proce-
dure for clustering highly immunogenic amino acids on
the linear sequence is performed since it is not naturally
evident as in the case of 3D structure output. Briefly, the
clustering procedure divides the sequence to stretches and
assigns each stretch a corresponding p-value, which is
defined as the probability of randomly obtaining an
equally-sized stretch with such a score or higher. The score
of a stretch is the sum of immunogenicity scores of the
amino acids comprising it. Practically, the p-value is com-
puted by shuffling all the scores in the sequence and
repeating the search procedure a large number of times.
Eventually, these clusters, ranked according to their statis-
tical significance (detailed in the 'OVERVIEW' web sec-
tion) are given as a text file link.
Results and discussion
Case studies
To illustrate the performance and functionality of the
Epitopia server two examples are given, one for a 3D struc-
ture input, and one for a sequence input. The 3D structure
model is of the human vascular endothelial growth factor
(VEGF), which was co-crystallized with its binding anti-
body (PDB: 1BJ1[18]). Figure 1 illustrates Epitopia's pre-
diction, when only the VEGF chain of the complex (chain
identifier W) was selected. The immunogenicity and prob-
ability scores (partly displayed in Figure 1A) are color-
coded and projected onto the structure model using the
FirstGlance in Jmol interface (Figure 1B). Figure 1C shows
that the region predicted to be the most immunogenic
largely overlaps the genuine epitope of the neutralizing
antibody, making it a highly successful prediction. The
FirstGlance interface further enables a wide range of dis-
play options for the graphical output such as increasing
the display quality, zoom control, and different chain dis-
play modes.
Figure 2 illustrates the prediction of Epitopia given the
amino-acid sequence of the Plasmodium falciparum Mero-
zoite surface antigen 2 (MSA-2) [Swiss-Prot: P19599]. Fig-
ure 2A presents a sample of the immunogenicity and
probability scores computed for this sequence, where Fig-
ure 2B displays the graphic visualization of these scores
color-coded and projected onto the sequence, along with
the predicted surface accessibility status for each amino
acid (whether it is buried or exposed). It is evident that the
region spanning amino acids 121 to 142 is highly immu-
nogenic. Correspondingly, the most significant immuno-
genic stretch according to Figure 2C lies between amino
acids 122 and 150. According to the Bcipep database [19],
a validated epitope for this sequence includes the stretch
between amino acids 125 to 131.
Comparing Epitopia to other B-cell epitope prediction 
tools
Conventionally, the area under the receiver operating
characteristic (ROC) curve (AUC) [20] is used for diagnos-
ing the performance of prediction methods (e.g., Pon-
omarenko and Bourne [21] used the AUC measure for
evaluating several B-cell epitope prediction methods). Yet
when it comes to assessing the performance of epitope
prediction methods, the AUC is somewhat inadequate. In
order to be able to compute the AUC, one has to define
which residues are true epitope residues and which are
non-epitope residues. It follows that any predictions
which are not part of any validated epitope are regarded as
false predictions. However, it is quite possible that the
tested antigen harbors a far larger number of epitopes
than are currently known, and thus the AUC underesti-
mates the actual predictive power of the prediction
method (this limitation was also noted by Ponomarenko
et al., [11]). We thus consider an additional measure to
evaluate the accuracy of prediction. Intuitively, in a suc-
cessful prediction, genuine epitope residues should be
scored higher than the average score of all residues.
Hence, we considered a prediction (for a single protein
input) to be successful if the average score of genuine
epitope residues exceeds the average score of all consid-
ered residues. Accordingly, we define the success rate of a
method as the number of successful predictions divided
by the total number of predictions. Our method's param-
eters were optimized to achieve such maximal ratio. We
also provide the AUC scores, which as noted above, pro-
vide a lower bound to the method's performance.
We compared Epitopia's performance to three other struc-
ture-based epitope prediction tools, CEP [9], DiscoTope
[10], and ElliPro [11], on the same data and using exactly
the same assessment measures. Epitopia succeeded in 59
out of the 66 predictions, yielding a success rate of 89.4%.
In comparison, DiscoTope and ElliPro succeeded in 54
and 53 predictions, giving success rates of 81.8% and
80.3%, respectively. Since CEP does not individually score
amino acids its performance could only be assessed using
the AUC (computed as described in [21]). CEP achieved a
mean AUC of 0.53 (over 65 cases, since a prediction for
one of the datasets, PDB ID: 3FFD could not be obtained),
which is substantially lower than that of all other methods
(mean AUCs of 0.6, 0.62, and 0.59 for Epitopia, Disco-
Tope, and ElliPro, respectively).
Epitopia was additionally compared to two sequence-
based tools, ABCpred [7] and COBEpro [8], which also
implement machine-learning algorithms and wereBMC Bioinformatics 2009, 10:287 http://www.biomedcentral.com/1471-2105/10/287
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trained on very similar data as Epitopia. Epitopia suc-
ceeded in 156 out of 194 predictions (success rate =
80.4%) with a mean AUC of 0.59. ABCpred succeeded in
130 out of 194 predictions (success rate = 67%) with a
mean AUC of 0.55. COBEpro succeeded in 119 out of 178
predictions (success rate = 66.9%), (16 antigen sequences
were discarded since they exceed COBEpro's sequence
length limit) with a mean AUC of 0.55.
We have selected the leave-one-out cross-validation pro-
cedure so that the performance of Epitopia is evaluated on
data different from that used to train the classifier (thus
avoiding over-fitting). In contrast, the performances of the
methods to which Epitopia was compared were not
achieved using cross-validation (thus, in most cases the
compared classifier was trained and evaluated on the
same data). Clearly, training and evaluating a method on
Illustration of Epitopia's prediction for the 3D structure of the VEGF [PDB: 1BJ1, chain W] Figure 1
Illustration of Epitopia's prediction for the 3D structure of the VEGF [PDB: 1BJ1, chain W]. (A) A sample of the 
immunogenicity and probability scores computed for each of the surface residues of the input structure. (B) The FirstGlance in 
Jmol interface presenting the color-coded immunogenicity scores projected onto the surface of the protein shown in spacefill. 
(C) Presentation of the VEGF structure, color-coded as in A, along with the backbones of the chains of its binding antibody 
[PDB: 1BJ1, chains L and H].
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the same data can artificially bias (increase) its perform-
ance.
Conclusion
The Epitopia algorithm treats the problem of epitope pre-
diction as a classical classification problem, applying the
most suitable methodology for tackling it. To this end,
Epitopia relies on an extensive set of physico-chemical
and structural-geometrical features that characterize
epitopes [6], which was optimized to yield maximal pre-
dictive power [12]. Although the Naïve Bayes classifier is
often claimed to be over-simplified [22], we note that a
support vector machine (SVM) classifier was also applied
to this problem but did not perform as well as the Naïve
Bayes classifier (data not shown). Thus, as the SVM classi-
fier is claimed to be second-to-best for most of the classi-
fication problems, we feel that the Naïve Bayes classifier is
an appropriate choice. Finally, it is worth emphasizing
that the performance assessment measure defined here
serves as a good alternative to the commonly used AUC
measure, so long as the validated data remain scant.
Although this new measure reports higher values than the
AUC, it does so for all the compared methods without
favoring any method in particular.
The Epitopia server provides ease of use, bifunctionality
(in handling both 3D structure and sequence inputs), and
rich output and visualization options that enable users to
delve into the prediction results. These features along with
the superiority of the Epitopia algorithm make up the
main advantages of the Epitopia server over other related
servers.
Availability and requirements
Project name: Epitopia
Project home page: http://epitopia.tau.ac.il
Operating system(s): Platform independent
Programming languages: C++, Perl
Any restrictions to use by non-academics: for non-com-
mercial research purposes only
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Illustration of Epitopia's prediction for the sequence of the P. falciparum MSA-2 [Swiss-Prot: P19599] Figure 2
Illustration of Epitopia's prediction for the sequence of the P. falciparum MSA-2 [Swiss-Prot: P19599]. (A) A sam-
ple of the immunogenicity and probability scores computed for each amino acid of the input sequence. (B) Projection of the 
color-coded immunogenicity scores onto the protein amino-acid sequence. (C) A sample of the most significant immunogenic 
stretches obtained by the clustering procedure.
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